"Endocannabinoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fatty acid derivatives that have specificity for CANNABINOID RECEPTORS. They are structurally distinct from CANNABINOIDS and were originally discovered as a group of endogenous CANNABINOID RECEPTOR AGONISTS.
Below are MeSH descriptors whose meaning is more general than "Endocannabinoids".
Below are MeSH descriptors whose meaning is more specific than "Endocannabinoids".
This graph shows the total number of publications written about "Endocannabinoids" by people in this website by year, and whether "Endocannabinoids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Endocannabinoids" by people in Profiles.
Genetic variation in endocannabinoid signaling is associated with differential network-level functional connectivity in youth. J Neurosci Res. 2022 03; 100(3):731-743.
The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence. Neuropsychopharmacology. 2021 04; 46(5):1020-1027.
Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults. J Clin Endocrinol Metab. 2020 03 01; 105(3).
Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020 01; 111:104471.
Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits. Psychoneuroendocrinology. 2019 12; 110:104434.
Circulating endocannabinoids and affect regulation in human subjects. Psychoneuroendocrinology. 2018 06; 92:66-71.
Endocannabinoid modulation of dopamine neurotransmission. Neuropharmacology. 2017 Sep 15; 124:52-61.
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation. Neuron. 2016 06 15; 90(6):1312-1324.
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol. Sleep. 2016 Mar 01; 39(3):653-64.
Interactions between ethanol and the endocannabinoid system at?GABAergic synapses on basolateral amygdala principal neurons. Alcohol. 2015 Dec; 49(8):781-94.